Efficacy Study of CHG Regimen vs Decitabine to Treat Higher-risk MDS
Condition(s):Myelodysplastic SyndromesLast Updated:September 9, 2016Unknown status
Hide Studies Not Open or Pending
Condition(s):Myelodysplastic SyndromesLast Updated:September 9, 2016Unknown status
Condition(s):COVID-19; SARS-CoV 2Last Updated:July 14, 2022Completed
Condition(s):Staphylococcus AureusLast Updated:February 7, 2024Completed
Condition(s):Malignant Female Reproductive System NeoplasmLast Updated:July 23, 2020Completed
Condition(s):ECL-cell Hyperplasia; Parietal-cell Hyperplasia; Rebound Hyperacidity; DyspepsiaLast Updated:December 3, 2015Completed
Condition(s):Methicillin-resistant Staphylococcus AureusLast Updated:January 31, 2023Completed
Condition(s):Hospitalization; InfectionLast Updated:December 27, 2023Completed
Condition(s):Respiratory Tract Neoplasms; Thymic Neoplasms; Pancreatic Neoplasms; Gastrointestinal Neoplasms; Multiple Endocrine NeoplasiaLast Updated:October 7, 2009Completed
Condition(s):Hemodialysis Catheter InfectionLast Updated:February 7, 2024Completed
Condition(s):Small Intestinal NET; Carcinoid Heart DiseaseLast Updated:February 5, 2020Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.